These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 24161907)

  • 1. Current status of medical treatment for abdominal aortic aneurysm.
    Kurosawa K; Matsumura JS; Yamanouchi D
    Circ J; 2013; 77(12):2860-6. PubMed ID: 24161907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicentre study of abdominal aortic aneurysm measurement and enlargement.
    Lederle FA; Noorbaloochi S; Nugent S; Taylor BC; Grill JP; Kohler TR; Cole L
    Br J Surg; 2015 Nov; 102(12):1480-7. PubMed ID: 26331269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the abdominal aortic aneurysm rupture rate decreasing?
    Lee AM; Chaikof EL
    Adv Surg; 2013; 47():271-86. PubMed ID: 24298856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenic and Therapeutic Significance of Angiotensin II Type I Receptor in Abdominal Aortic Aneurysms.
    Xu B; Xuan H; Iida Y; Miyata M; Dalman RL
    Curr Drug Targets; 2018; 19(11):1318-1326. PubMed ID: 29359665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Theories and Clinical Trial Evidence for Limiting Human Abdominal Aortic Aneurysm Growth.
    Yu J; Liu S; Huang J; Wang W
    Curr Drug Targets; 2018; 19(11):1302-1308. PubMed ID: 29141546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MMP inhibition in abdominal aortic aneurysms. Rationale for a prospective randomized clinical trial.
    Thompson RW; Baxter BT
    Ann N Y Acad Sci; 1999 Jun; 878():159-78. PubMed ID: 10415728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological Therapy of Abdominal Aortic Aneurysm: An Update.
    Wang YD; Liu ZJ; Ren J; Xiang MX
    Curr Vasc Pharmacol; 2018 Jan; 16(2):114-124. PubMed ID: 28412911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of gender on presentation, therapy, and mortality of abdominal aortic aneurysm in the United States, 2001-2004.
    McPhee JT; Hill JS; Eslami MH
    J Vasc Surg; 2007 May; 45(5):891-9. PubMed ID: 17391899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxycycline therapy for abdominal aneurysm: Improved proteolytic balance through reduced neutrophil content.
    Abdul-Hussien H; Hanemaaijer R; Verheijen JH; van Bockel JH; Geelkerken RH; Lindeman JH
    J Vasc Surg; 2009 Mar; 49(3):741-9. PubMed ID: 19268776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with small abdominal aortic aneurysm expansion rate.
    Bhak RH; Wininger M; Johnson GR; Lederle FA; Messina LM; Ballard DJ; Wilson SE;
    JAMA Surg; 2015 Jan; 150(1):44-50. PubMed ID: 25389641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical management of abdominal aortic aneurysms.
    Weiss N; Rodionov RN; Mahlmann A
    Vasa; 2014 Nov; 43(6):415-21. PubMed ID: 25339159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endovascular Repair of Ruptured Abdominal Aortic Aneurysm Is Associated with Lower Incidence of Post-operative Acute Renal Failure.
    Aziz F; Azab A; Schaefer E; Reed AB
    Ann Vasc Surg; 2016 Aug; 35():147-55. PubMed ID: 27236089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of matrix metalloproteinase inhibitors in preventing abdominal aortic aneurysm.
    Aziz F; Kuivaniemi H
    Ann Vasc Surg; 2007 May; 21(3):392-401. PubMed ID: 17484978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. To what extent has endovascular aneurysm repair influenced abdominal aortic aneurysm management in the state of Illinois?
    Leon LR; Labropoulos N; Laredo J; Rodríguez HE; Kalman PG
    J Vasc Surg; 2005 Apr; 41(4):568-74. PubMed ID: 15874918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preadmission use of renin-angiotensin blockers and rupture of abdominal aortic aneurysm: a nationwide, population-based study.
    Wemmelund H; Høgh A; Hundborg HH; Johnsen SP; Lindholt JS
    Pharmacoepidemiol Drug Saf; 2016 Feb; 25(2):141-50. PubMed ID: 26817783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of diabetes on abdominal aortic aneurysm growth over 2 years.
    Nordness MJ; Baxter BT; Matsumura J; Terrin M; Zhang K; Ye F; Webb NR; Dalman RL; Curci JA
    J Vasc Surg; 2022 Apr; 75(4):1211-1222.e1. PubMed ID: 34695550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Annual rupture risk of abdominal aortic aneurysm enlargement without detectable endoleak after endovascular abdominal aortic repair.
    Koole D; Moll FL; Buth J; Hobo R; Zandvoort HJ; Bots ML; Pasterkamp G; van Herwaarden JA;
    J Vasc Surg; 2011 Dec; 54(6):1614-22. PubMed ID: 21917405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endovascular abdominal aortic aneurysm repair: long-term outcome measures in patients at high-risk for open surgery.
    Sicard GA; Zwolak RM; Sidawy AN; White RA; Siami FS;
    J Vasc Surg; 2006 Aug; 44(2):229-36. PubMed ID: 16690242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endovascular aortic aneurysm repair by a multidisciplinary team: lessons learned and six-year clinical update.
    Du Toit DF; Saaiman JA; Carpenter JP; Geldenhuys KM
    Cardiovasc J S Afr; 2005; 16(1):36-47. PubMed ID: 15778773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with abdominal aortic aneurysms: nation-wide cohort study.
    Kristensen KE; Torp-Pedersen C; Gislason GH; Egfjord M; Rasmussen HB; Hansen PR
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):733-40. PubMed ID: 25633315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.